NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE Arca · Health · USD · ETF

State Street Health Care Select Sector SPDR ETF (XLV) ETF Analysis

XLV
Expense ratio 0.08% Yield 1.49% Assets $43.91B Since December 16, 1998 Family State Street Investment Management
$171.45
−$1.81 (−1.04%)

September 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare XLV with… →

Key facts

As of September 4, 2026, the annualized return for XLV over 10 years is +10.81%.

XLV charges an expense ratio of 0.08%.

XLV has $43.91B in net assets.

XLV Annualized Returns

PeriodAnnualized$100 becomes
1 year+26.93%$126.93
3 years+10.51%$134.98
5 years+6.32%$135.86
10 years+10.81%$279.00

Returns are price returns computed from daily closes and exclude dividends. As of September 4, 2026.

XLV Return by Calendar Year

2016 and 2026 are partial years

View as table ↓View as chart ↑
YearReturn
2026 (partial year)+11.70%
2025+14.50%
2024+2.47%
2023+2.07%
2022−2.08%
2021+26.04%
2020+13.30%
2019+20.45%
2018+6.28%
2017+21.77%
2016 (partial year)−6.83%

XLV Monthly Returns

−10%+13%
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026−0.0+3.5−8.1−0.4+2.4+6.6+2.5+4.9+0.5———
2025+6.8+1.4−1.6−3.8−5.6+2.1−3.2+5.4+1.7+3.7+9.3−1.4
2024+2.9+3.2+2.4−5.0+2.4+1.8+2.7+5.1−1.7−4.6+0.4−6.3
2023−1.8−4.6+2.2+3.1−4.3+4.3+1.1−0.7−3.0−3.3+5.4+4.3
2022−6.9−1.0+5.7−4.9+1.5−2.6+3.2−5.8−2.5+9.6+4.7−1.9
2021+1.4−2.1+4.0+3.9+1.9+2.3+4.9+2.3−5.5+5.1−3.1+9.0
2020−2.7−6.6−3.9+12.6+3.3−2.4+5.5+2.6−2.2−3.6+7.9+3.8
2019+4.8+1.1+0.5−2.7−2.2+6.6−1.6−0.6−0.1+5.1+5.0+3.5
2018+6.6−4.5−2.9+1.1+0.2+1.6+6.6+4.3+3.0−6.8+8.1−9.4
2017+2.3+6.3−0.5+1.5+0.8+4.6+0.8+1.8+0.9−0.8+2.9−0.6

Monthly price returns computed from daily closes; each cell prints its signed value.

XLV Volatility & Risk

Volatility: 10 yrs · Beta: 3 yrs
Annualized volatility
16.73%
Beta (3y)
0.52
Best year
+26.04%

2021

Worst year
−2.08%

2022

Volatility is the annualized standard deviation of daily returns. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Top Holdings

# Symbol Name Weight
1 LLY Eli Lilly and Co 15.47%
2 JNJ Johnson & Johnson 10.51%
3 ABBV AbbVie Inc 7.55%
4 UNH UnitedHealth Group Inc 6.41%
5 MRK Merck & Co Inc 5.47%
6 TMO Thermo Fisher Scientific Inc 3.63%
7 AMGN Amgen Inc 3.54%
8 ABT Abbott Laboratories 3.13%
9 GILD Gilead Sciences Inc 2.75%
10 PFE Pfizer Inc 2.43%

Analysis

Data-derived

Fund Overview

State Street Health Care Select Sector SPDR ETF (XLV) is an exchange-traded fund in the Health category. The fund is issued by State Street Investment Management. The inception date on file is December 16, 1998. The fund holds $43.91B in total net assets. The expense ratio is 0.08%. On a $10,000 position that is $8.00 a year.

Its biggest positions are Eli Lilly and Co (LLY), Johnson & Johnson (JNJ), and AbbVie Inc (ABBV). Eli Lilly and Co alone accounts for 15.47% of the portfolio. The ten largest positions together make up 60.89% of the fund.

Performance Analysis

XLV last closed at $171.45 on September 4, 2026. The trailing one-year price return is +26.93%. Across 10 years the annualized return works out at +10.81%. The trailing distribution yield is 1.49%.

So far in 2026 the price is +11.70%. The strongest complete calendar year on file is 2021 at +26.04%; the weakest is 2022 at −2.08%. Of the 9 complete calendar years on file, 8 finished higher.

Price & Risk Profile

Daily returns over the trailing 10 years annualize to a volatility of 16.73%. Beta against the wider market is reported at 0.52. The 52-week range on file runs from $133.73 to $176.60. The latest close sits 28.21% above that 52-week low. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health ETFs

VHT

Vanguard Health Care Index Fund ETF Shares

$21.93B

 XBI

State Street SPDR S&P Biotech ETF

$11.40B

 IBB

iShares Biotechnology ETF

$10.47B

 ARKG

ARK Genomic Revolution ETF

$2.02B
View all Health ETFs →